Sign in

CIK 0001604821

  • Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010894487
Phone
+1 650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$104,832,418
in 28 filings, $104.8M under 10b5-1 plans

Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-01-29 Chapman Steven Leonard CEO AND PRESIDENT Sale −14,813 $65.09 $964K 246,957
2024-01-29 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale −3,426 $65.09 $223K 194,977
2024-01-29 Fesko John PRESIDENT, CHIEF BUS. OFFICER Sale −2,358 $65.09 $153K 108,494
2024-01-26 Rabinowitz Matthew EXECUTIVE CHAIRMAN Grant or award +68,976 1,072,556
2024-01-26 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Grant or award +31,352 96,162
2024-01-26 Sheena Jonathan Director Grant or award +9,405 479,131
2024-01-26 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Grant or award +27,433 208,483
2024-01-26 Chapman Steven Leonard CEO AND PRESIDENT Grant or award +86,220 261,770
2024-01-26 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Grant or award +31,352 198,403
2024-01-26 Fesko John PRESIDENT, CHIEF BUS. OFFICER Grant or award +31,352 110,852
2024-01-26 ROSENMAN HERM Director Grant or award +303 $63.79 $19K 61,685
2024-01-26 HEALY JAMES Director Grant or award +264 $63.79 $17K 42,500
2024-01-26 BOTHA ROELOF Director Grant or award +352 $63.79 $22K 352
2024-01-26 Baynes Roy D. Director Grant or award +215 $63.79 $14K 12,407
2024-01-24 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −944 $67.00 $63K 64,810
2024-01-23 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −306 $66.81 $20K 67,650
2024-01-23 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −1,896 $65.70 $125K 65,754
2024-01-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +1,250 68,727
2024-01-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale 10b5-1 −771 $68.16 $53K 67,956
2024-01-22 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Exercise or conversion · Restricted Stock Unit 10b5-1 −1,250 8,750

Page 81 of 85 · 1,682 trades